Circadian-dependent autophagy in retinal maintenance and diabetes

昼夜节律依赖性自噬在视网膜维护和糖尿病中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): The removal of damaged mitochondria and other organelles by autophagy is an essential housekeeping function in all tissues. However, there is increasing evidence that the accumulation of damaged mitochondria contributes to the neurovascular complications associated with diabetes. Our preliminary data show that autophagy proteins are expressed at high levels in healthy retina but are dramatically reduced within the neurovascular diabetic retina, suggesting that the age-related decrease in autophagic proteolysis observed in tissues will be intensified in the diabetic with increasing duration of disease. Moreover, there is a disturbed circadian rhythm in diabetic humans and animals. However, the impact of circadian dysfunction on autophagy in the neurovascular retina is unknown. Our preliminary investigations in mice show that the autophagy proteins Atg9 and LC3 are highest in the retina at around 8:15 am and 8:15 pm, in contrast, Beclin expression was highest at midnight. These observations suggest that in retinal neurovascular tissue, autophagy shows circadian rhythmicity independent of feeding cycles or light cycle. We also show in vitro that endothelial cells in which the peripheral clock has been synchronized demonstrate a peak in autophagy flux which is lost when the clock protein Bmal1 is knocked down. Based on these novel preliminary findings, we put forward the following hypothesis: Circadian-regulated autophagy plays a critical role in neurovascular cell homeostasis within the retina and that diabetes alters this circadian rhythmicity leading to dysregulated autophagy and diabetic retinopathy. To test our hypothesis we propose the following aims: 1) to confirm that in healthy mice autophagy in neural and vascular cells of the retina is under circadian regulation; 2) to determine how autophagy is altered following retinal cell-specific clock gene knockdown in mice and if this is associated with functional defects of the neurovascular retina; 3) to determine whether autophagic flux and its circadian pattern is altered in neural and vascular cells of the retina of STZ diabetic mice. The data generated will provide novel insights into the pathogenesis of diabetic retinopathy and may identify autophagic proteins as new therapeutic targets for DR.
描述(由申请人提供):通过自噬去除受损的线粒体和其他细胞器是所有组织中重要的管家功能。然而,越来越多的证据表明受损线粒体的积累会导致与糖尿病相关的神经血管并发症。我们的初步数据显示,自噬蛋白在健康视网膜中高水平表达,但在神经血管糖尿病视网膜内显着减少,这表明在组织中观察到的自噬蛋白水解与年龄相关的减少在糖尿病患者中随着病程的延长而加剧。此外,患有糖尿病的人类和动物的昼夜节律受到干扰。然而,昼夜节律功能障碍对神经血管视网膜自噬的影响尚不清楚。我们对小鼠的初步研究表明,自噬蛋白 Atg9 和 LC3 在上午 8:15 和晚上 8:15 左右在视网膜中表达最高,相比之下,Beclin 表达在午夜最高。这些观察结果表明,在视网膜神经血管组织中,自噬表现出与进食周期或光周期无关的昼夜节律。我们还在体外证明,外周时钟已同步的内皮细胞表现出自噬通量峰值,当时钟蛋白 Bmal1 被敲低时,自噬通量就会消失。基于这些新颖的初步发现,我们提出以下假设:昼夜节律调节的自噬在视网膜内神经血管细胞稳态中发挥着关键作用,糖尿病改变了这种昼夜节律,导致自噬失调和糖尿病视网膜病变。为了检验我们的假设,我们提出以下目标:1)确认健康小鼠视网膜神经和血管细胞的自噬处于昼夜节律调节之下; 2) 确定小鼠视网膜细胞特异性时钟基因敲低后自噬如何改变,以及这是否与神经血管视网膜的功能缺陷有关; 3) 确定STZ糖尿病小鼠视网膜神经细胞和血管细胞的自噬通量及其昼夜节律模式是否发生改变。生成的数据将为糖尿病视网膜病变的发病机制提供新的见解,并可能将自噬蛋白确定为 DR 的新治疗靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Edwin Boulton其他文献

Michael Edwin Boulton的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Edwin Boulton', 18)}}的其他基金

ACE2 on gut barrier dysfunction and BRB disruption
ACE2 对肠道屏障功能障碍和 BRB 破坏的影响
  • 批准号:
    10535485
  • 财政年份:
    2022
  • 资助金额:
    $ 12.61万
  • 项目类别:
ACE2 on gut barrier dysfunction and BRB disruption
ACE2 对肠道屏障功能障碍和 BRB 破坏的影响
  • 批准号:
    10379018
  • 财政年份:
    2022
  • 资助金额:
    $ 12.61万
  • 项目类别:
A critical role for intracellular VEGF receptor translocation in ocular angiogenesis
细胞内 VEGF 受体易位在眼部血管生成中的关键作用
  • 批准号:
    9920715
  • 财政年份:
    2018
  • 资助金额:
    $ 12.61万
  • 项目类别:
Somatostatin blockade of CNS autonomic hyperactivity for treatment of diabetic retinopathy
生长抑素阻断中枢神经系统自主神经亢进治疗糖尿病视网膜病变
  • 批准号:
    9403831
  • 财政年份:
    2017
  • 资助金额:
    $ 12.61万
  • 项目类别:
LXR as a novel therapeutic target in diabetic retinopathy
LXR作为糖尿病视网膜病变的新型治疗靶点
  • 批准号:
    8987391
  • 财政年份:
    2015
  • 资助金额:
    $ 12.61万
  • 项目类别:
Autophagy: A critical factor in RPE aging and AMD
自噬:R​​PE 老化和 AMD 的关键因素
  • 批准号:
    8698871
  • 财政年份:
    2013
  • 资助金额:
    $ 12.61万
  • 项目类别:
Optimizing systemic stem/progenitor cell therapy for AMD
优化 AMD 的全身干/祖细胞治疗
  • 批准号:
    8917964
  • 财政年份:
    2013
  • 资助金额:
    $ 12.61万
  • 项目类别:
Optimizing systemic stem/progenitor cell therapy for AMD
优化 AMD 的全身干/祖细胞治疗
  • 批准号:
    8561485
  • 财政年份:
    2013
  • 资助金额:
    $ 12.61万
  • 项目类别:
Non-canonical VEGF receptor signaling regulates retinal neovascularization
非经典 VEGF 受体信号传导调节视网膜新生血管形成
  • 批准号:
    8722755
  • 财政年份:
    2013
  • 资助金额:
    $ 12.61万
  • 项目类别:
OPTIMIZING SYSTEMIC STEM/PROGENITOR CELL THERAPY FOR AMD
优化 AMD 的系统干细胞/祖细胞治疗
  • 批准号:
    9507559
  • 财政年份:
    2013
  • 资助金额:
    $ 12.61万
  • 项目类别:

相似海外基金

Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
  • 批准号:
    10638439
  • 财政年份:
    2023
  • 资助金额:
    $ 12.61万
  • 项目类别:
Hypothalamic Sleep-Wake Neuron Defects in Alzheimer’s disease
阿尔茨海默病中的下丘脑睡眠-觉醒神经元缺陷
  • 批准号:
    10770001
  • 财政年份:
    2023
  • 资助金额:
    $ 12.61万
  • 项目类别:
Amnion cell secretome mediated therapy for traumatic brain injury
羊膜细胞分泌组介导的创伤性脑损伤治疗
  • 批准号:
    10746655
  • 财政年份:
    2023
  • 资助金额:
    $ 12.61万
  • 项目类别:
Glymphatic impairment as a crucial factor in particulate matter exposure related development of Alzheimer's disease pathology
类淋巴系统损伤是与颗粒物暴露相关的阿尔茨海默病病理学发展的关键因素
  • 批准号:
    10718104
  • 财政年份:
    2023
  • 资助金额:
    $ 12.61万
  • 项目类别:
Targeting microglial cell iron-handling in Alzheimer’s Disease
靶向阿尔茨海默病中的小胶质细胞铁处理
  • 批准号:
    10603992
  • 财政年份:
    2023
  • 资助金额:
    $ 12.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了